The Amyloid-beta Oligomer Hypothesis: Beginning of the Third Decade
An investigational GLP-1 pill from Eli Lilly helped diabetes patients lower their blood sugar and weight more than an oral version of Ozempic sold by Novo Nordisk, results that support the efficacy of Lillys medicine as the company prepares to submit it to regulators
Consider the implications of this work: a large precursor protein is processed in a cell type-specific fashion, leading to the production of several smaller peptide hormones
Please note that these are merely associations as they appear in the given model and do not represent effects that may be interpreted in any causal manner
External resources Phase 2 clinical trial: Once-weekly cagrilintide for weight management (The Lancet) REDEFINE 1: Coadministered cagrilintide and semaglutide (NEJM) Systematic review: Efficacy and safety of cagrilintide alone and in combination (PMC) For researchers serious about navigating cagrilintide protocols safely, SeekPeptides provides comprehensive, evidence-based guides, dosing tools, and a community of experienced researchers who have worked through these exact questions
But with so much misinformation online, how do you know whats safe